MV4-11 Cells
CAD$545.10*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Essential facts about the MV4-11 cell line
| Description | The MV-4-11 cell line, isolated from the blast cells of a child with biphenotypic B-myelomonocytic leukemia, serves as a critical resource in the study of acute leukemias, particularly acute myeloid leukemia (AML). MV4-11 cells are characterized by their high proliferation rate and the presence of certain genetic abnormalities. A translocation between chromosomes 4 and 11 leads to the creation of the MLL-AF4 fusion gene, which plays a crucial role in leukemogenesis and contributes to the aggressive nature of leukemia. The presence of the MLL-AF4 fusion gene makes these cells particularly relevant for understanding the molecular mechanisms underlying leukemogenesis and studies on targeted therapies that aim to disrupt the function of this oncogenic fusion protein. Additionally, MV4-11 cells can be used to study the biology of leukemia stem cells, drug resistance mechanisms, and the role of the bone marrow microenvironment in leukemia progression. The cell line is further instrumental in metabolomics and transcriptomic profiles research, providing a comprehensive understanding of the metabolic alterations and redox adaptation in leukemia. The ability of MV-4-11 cells to respond to various cancer research chemicals, including inhibitors like venetoclax, and their role in studying resistant cells. In conclusion, the MV-4-11 cell line is a crucial tool in leukemia research, offering a versatile platform for investigating the complex biology of acute myeloid leukemia, testing the efficacy of therapeutic agents, and exploring the potential of targeted treatments in overcoming drug resistance. |
|---|---|
| Organism | Human |
| Tissue | Blood |
| Disease | Acute monocytic leukemia |
| Synonyms | MV-4-11, MV-4:11, MV4:11, MV 4,11, MV4,11, MV411, MV(4,11), |
Aspects of myelomonocytic leukemia cells MV4-11
| Age | 10 years |
|---|---|
| Gender | Male |
| Ethnicity | Caucasian |
| Morphology | Round cells |
| Cell type | Myelomonocytic, biphenotypic |
| Growth properties | Suspension |
Documentation
| Citation | MV4-11 (Cytion catalog number 300295) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_0064 |
Genotype
| Antigen expression | CD4 (40-96%), CD10 (4-11%), CD15 (96-99%) |
|---|---|
| Mutational profile | FLT3mut (a FLT3 internal tandem duplication was verified by PCR) |
| Karyotype | 48, xY, t(4,11)(q21,q23), +8, +19 |
MC4-11 cell culture recommendations
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Subculturing | Maintain cultures by periodically adding or replacing the medium. Initiate cultures with a density of 5 x 105 cells/ml and keep the cell concentration within the range of 3 x 105 to 1 x 106 cells/ml for optimal growth. |
| Seeding density | 5 x 105 cells/mL |
| Post-Thaw Recovery | Please allow the cells to recover from the freezing process for at least 48 hours. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Genetic profile of the acute myeloid leukemia cell line MV4-11
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300295-271023 | Certificate of Analysis | 23. May. 2025 | 300295 |
| 300295-160525 | Certificate of Analysis | 21. Jul. 2025 | 300295 |